These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31114697)

  • 1. Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.
    Baqar S; Straznicky NE; Lambert G; Kong YW; Dixon JB; Jerums G; Ekinci EI; Lambert E
    BMJ Open Diabetes Res Care; 2019; 7(1):e000606. PubMed ID: 31114697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Salt Supplementation on Sympathetic Activity and Endothelial Function in Salt-Sensitive Type 2 Diabetes.
    Baqar S; Kong YW; Chen AX; O'Callaghan C; MacIsaac RJ; Bouterakos M; Lambert GW; Jerums G; Lambert EE; Ekinci EI
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31761946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
    Front Physiol; 2016; 7():516. PubMed ID: 27857694
    [No Abstract]   [Full Text] [Related]  

  • 4. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory modulation of sympathetic transduction to blood pressure in health and type 2 diabetes.
    Plunkett MJ; Holwerda S; Young BE; Fadel PJ; Fisher JP
    J Physiol; 2024 Aug; 602(16):3909-3927. PubMed ID: 39073892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Central Blood Pressure in Response to Oral Glucose Loading Is Blunted in Patients With Diabetes Mellitus.
    Higaki T; Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Iwasaki T; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Am J Hypertens; 2016 Mar; 29(3):357-64. PubMed ID: 26208673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between habitual dietary sodium intake and RAAS blockade on circulating microparticle levels in type two diabetes.
    Baqar S; Liu D; Lincz LF; Kong YW; Jerums G; Ekinci EI
    Clin Sci (Lond); 2018 Oct; 132(20):2207-2220. PubMed ID: 30249722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic Transduction in Type 2 Diabetes Mellitus.
    Young BE; Holwerda SW; Vranish JR; Keller DM; Fadel PJ
    Hypertension; 2019 Jul; 74(1):201-207. PubMed ID: 31188673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
    Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baroreflex impairment by low sodium diet in mild or moderate essential hypertension.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Bolla G; Mancia G
    Hypertension; 1997 Mar; 29(3):802-7. PubMed ID: 9052899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance.
    Dimova R; Tankova T; Guergueltcheva V; Tournev I; Chakarova N; Grozeva G; Dakovska L
    J Diabetes Complications; 2017 Mar; 31(3):537-543. PubMed ID: 27894750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss.
    Lambert EA; Rice T; Eikelis N; Straznicky NE; Lambert GW; Head GA; Hensman C; Schlaich MP; Dixon JB
    Am J Hypertens; 2014 Oct; 27(10):1308-15. PubMed ID: 24717419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modest Salt Reduction Lowers Blood Pressure and Albumin Excretion in Impaired Glucose Tolerance and Type 2 Diabetes Mellitus: A Randomized Double-Blind Trial.
    Suckling RJ; He FJ; Markandu ND; MacGregor GA
    Hypertension; 2016 Jun; 67(6):1189-95. PubMed ID: 27160199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes and impaired glucose tolerance among cardiac patients.
    Enquobahrie DA; Dolidze N; Chapidze G; Vadachkoria S; Soh J; Fitzpatrick A; Williams MA
    Acta Cardiol; 2007 Oct; 62(5):439-44. PubMed ID: 17982963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.